Alliancebernstein L.P. Ultragenyx Pharmaceutical Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,546,265 shares of RARE stock, worth $66.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,546,265

Previous 1,527,875 1.2%

Holding current value

$66.5 Million

Previous $62.8 Million 36.79%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $739,461 - $1.09 Million	18,390 Added 1.2%	1,546,265 $85.9 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $1.7 Million - $2.34 Million	45,404 Added 3.06%	1,527,875 $62.8 Million
Q1 2024 May 14, 2024	SELL	$43.02 - $53.69 $4.14 Million - $5.16 Million	-96,132 Reduced 6.09%	1,482,471 $69.2 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $1.46 Million - $2.27 Million	46,098 Added 3.01%	1,578,603 $75.5 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $654,330 - $874,315	18,738 Added 1.24%	1,532,505 $54.6 Million
Q2 2023 Aug 15, 2023	BUY	$37.35 - $52.15 $3.15 Million - $4.4 Million	84,353 Added 5.9%	1,513,767 $69.8 Million
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $4.15 Million - $5.47 Million	-112,263 Reduced 7.28%	1,429,414 $57.3 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $7.69 Million - $10.6 Million	228,144 Added 17.37%	1,541,677 $71.4 Million
Q3 2022 Nov 15, 2022	BUY	$39.96 - $66.14 $3.17 Million - $5.25 Million	79,409 Added 6.43%	1,313,533 $54.4 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $6.38 Million - $11.9 Million	-139,305 Reduced 10.14%	1,234,124 $73.6 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $4.06 Million - $5.51 Million	65,273 Added 4.99%	1,373,429 $99.7 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $11.2 Million - $13.4 Million	152,002 Added 13.15%	1,308,156 $110 Million
Q3 2021 Nov 10, 2021	SELL	$77.92 - $102.4 $2 Million - $2.63 Million	-25,693 Reduced 2.17%	1,156,154 $104 Million
Q2 2021 Jul 30, 2021	BUY	$92.19 - $115.71 $3.17 Million - $3.98 Million	34,414 Added 3.0%	1,181,847 $113 Million
Q1 2021 May 06, 2021	SELL	$106.9 - $167.73 $4.29 Million - $6.73 Million	-40,136 Reduced 3.38%	1,147,433 $131 Million
Q4 2020 Feb 08, 2021	SELL	$84.4 - $177.39 $16.4 Million - $34.4 Million	-193,983 Reduced 14.04%	1,187,569 $164 Million
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $2.49 Million - $3.07 Million	-34,144 Reduced 2.41%	1,381,552 $114 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $124,546 - $207,674	2,655 Added 0.19%	1,415,696 $111 Million
Q1 2020 May 14, 2020	SELL	$33.8 - $62.9 $4.54 Million - $8.45 Million	-134,352 Reduced 8.68%	1,413,041 $62.8 Million
Q4 2019 Feb 18, 2020	BUY	$36.08 - $45.83 $7.64 Million - $9.7 Million	211,635 Added 15.84%	1,547,393 $66.1 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $7.23 Million - $10.7 Million	170,136 Added 14.6%	1,335,758 $57.1 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $1.94 Million - $2.63 Million	35,390 Added 3.13%	1,165,622 $74 Million
Q1 2019 May 14, 2019	BUY	$39.87 - $69.36 $4.86 Million - $8.46 Million	122,009 Added 12.1%	1,130,232 $78.4 Million
Q4 2018 Feb 13, 2019	BUY	$38.89 - $77.3 $617,028 - $1.23 Million	15,866 Added 1.6%	1,008,223 $43.8 Million
Q3 2018 Nov 08, 2018	BUY	$71.81 - $90.15 $3.63 Million - $4.55 Million	50,489 Added 5.36%	992,357 $75.8 Million
Q2 2018 Aug 13, 2018	BUY	$48.54 - $85.31 $2.16 Million - $3.8 Million	44,556 Added 4.97%	941,868 $72.4 Million
Q1 2018 May 14, 2018	BUY	$44.33 - $58.52 $8.73 Million - $11.5 Million	196,906 Added 28.11%	897,312 $45.8 Million
Q4 2017 Feb 13, 2018	BUY	$43.54 - $57.32 $2.44 Million - $3.22 Million	56,106 Added 8.71%	700,406 $32.5 Million
Q3 2017 Nov 13, 2017	BUY	$49.79 - $66.32 $32.1 Million - $42.7 Million	644,300	644,300 $34.3 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ultragenyx Pharmaceutical Inc. Transaction History